NOSOTEQ Trademark

Trademark Overview

On Monday, September 8, 2003, a trademark application was filed for NOSOTEQ with the United States Patent and Trademark Office. The USPTO has given the NOSOTEQ trademark a serial number of 78297321. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 27, 2013. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The NOSOTEQ trademark is filed in the Pharmaceutical Products category with the following description:

monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus

General Information

Serial Number78297321
Word MarkNOSOTEQ
Filing DateMonday, September 8, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 27, 2013
Registration Number3210103
Registration DateTuesday, February 20, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2006

Trademark Statements

Goods and Servicesmonoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRIXENSART B-1330
BE
Party NameGLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRIXENSART B-1330
BE
Party NameGLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressRIXENSART B-1330
BE
Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Friday, September 27, 2013CANCELLED SEC. 8 (6-YR)
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 20, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2006NOTICE OF PUBLICATION
Tuesday, October 31, 2006ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, July 5, 2006ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, June 16, 2006ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 17, 2006ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 7, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 13, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 5, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 5, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 30, 2005LETTER OF SUSPENSION E-MAILED
Wednesday, November 30, 2005SUSPENSION LETTER WRITTEN
Wednesday, November 23, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, November 16, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 16, 2005FAX RECEIVED
Monday, November 14, 2005LETTER OF SUSPENSION E-MAILED
Monday, November 14, 2005SUSPENSION LETTER WRITTEN
Tuesday, November 8, 2005EXAMINER'S AMENDMENT ENTERED
Wednesday, November 2, 2005EXAMINERS AMENDMENT E-MAILED
Wednesday, November 2, 2005EXAMINERS AMENDMENT -WRITTEN
Thursday, July 14, 2005LETTER OF SUSPENSION E-MAILED
Thursday, July 14, 2005SUSPENSION LETTER WRITTEN
Thursday, July 14, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, September 1, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 24, 2004ASSIGNED TO LIE
Wednesday, September 1, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 5, 2004NON-FINAL ACTION E-MAILED
Thursday, March 4, 2004ASSIGNED TO EXAMINER

Related Keywords

nosoteq staphylococcal particular infections epidermidis aureus bacterial susceptible treatment antibodies birth